| Ref ID | 846 |
| First Author | R. Basirat |
| Journal | HEALTH SCIENCE REPORTS |
| Year Of Publishing | 2023 |
| URL | https://onlinelibrary-wiley-com.sheffield.idm.oclc.org/doi/10.1002/hsr2.1133 |
| Keywords |
• Cochrane • Equity • Urology |
| Problem(s) |
• Weaknesses identified in some Cochrane reviews • Failure to consider equity, different socioeconomic groups or disadvantaged populations |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Iran |
| Checklists |
• PROGRESS |
| Aim | To evaluate equity considerations in Cochrane reviews and the included primary studies on the prevention and management of urolithiasis. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 12 Cochrane reviews on the prevention and management of urolithiasis published in the Cochrane Database of Systematic Reviews up to January 1, 2022. The authors of Cochrane systematic reviews on urolithiasis rarely considered health equity dimensions when designing and performing their studies. None of the 12 included Cochrane reviews had specifically mentioned the PROGRESS framework in the method section whereas gender distribution and place of residence were reported in two and one reviews, respectively. Neither of the included reviews had assessed the difference of the intervention effect on any of the PROGRESS items. |
| Number of systematic reviews included | 12 |
| Number of eligible systematic reviews assessed | 12 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |